The impact of the tumor immune microenvironment on response to pembrolizumab in patients with microsatellite instability-high endometrial cancer.

被引：0
|
作者：
How, Jeffrey A. [1 ]
Dao, Minghao [1 ]
Euscher, Elizabeth [1 ]
Yates, Melinda [1 ]
Peng, Weiyi [2 ]
Patel, Shrina D. [1 ]
Lu, Karen H. [1 ]
Hwu, Patrick [1 ]
Wang, Linghua [1 ]
Jazaeri, Amir A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Houston, Houston, TX USA
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO015
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
    Toshida, Katsuya
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Shimagaki, Tomonari
    Wang, Huanlin
    Kurihara, Takeshi
    Toshima, Takeo
    Nagao, Yoshihiro
    Harada, Noboru
    Oki, Eiji
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    Mori, Masaki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1459 - 1463
  • [32] Chemotherapy for resectable microsatellite instability-high gastric cancer?
    Lordick, Florian
    Smyth, Elizabeth C.
    LANCET ONCOLOGY, 2020, 21 (02): : 203 - 204
  • [33] Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer
    Kim, Jin Won
    Cho, Sung-Yup
    Chae, Jeesoo
    Kim, Ji-Won
    Kim, Tae-Yong
    Lee, Keun-Wook
    Oh, Do-Youn
    Bang, Yung-Jue
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1178 - 1187
  • [34] Adjuvant chemoradiation associated with improved outcomes in patients with microsatellite instability-high advanced endometrial carcinoma
    McEachron, Jennifer
    Zhou, Nancy
    Spencer, Christina
    Chatterton, Carolyn
    Shanahan, Lisa
    Katz, Julie
    Naegele, Saskia
    Singhal, Pankaj K.
    Lee, Yi-Chun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (02) : 203 - 208
  • [35] Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.
    Sinicrope, Frank A.
    Chakrabarti, Sakti
    Eiring, Rachel
    Mitchelll, Jessica L.
    Finnes, Heidi D.
    Hubbard, Joleen Marie
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
    Yoshida, Tsukasa
    Yaegashi, Hiroshi
    Toriumi, Ren
    Kadomoto, Suguru
    Iwamoto, Hiroaki
    Izumi, Kouji
    Kadono, Yoshifumi
    Ikeda, Hiroko
    Mizokami, Atsushi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
    Guedikian, Annie A.
    Randall, Megan E.
    Sharko, Anita
    Leslie, William T.
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1414 - 1417
  • [38] Immune checkpoint inhibitors for patients with microsatellite instability-high colorectal cancer: protocol of a pooled analysis of clinical trials
    Tang, Xiaojun
    Xu, Xinshu
    Chen, Ruobing
    Zhang, Mengmeng
    Mei, Zubing
    Zhang, Shuangxi
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [39] Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future
    Sahin, Ibrahim Halil
    Zhang, Janie
    Saridogan, Turcin
    Gorantla, Vikram
    Rhree, John
    Malhotra, Monica
    Thomas, Roby
    Hsu, Dennis
    Saeed, Anwaar
    JCO ONCOLOGY PRACTICE, 2023, 19 (05) : 251 - +
  • [40] Microsatellite instability-high in Japanese patients with hepatocellular carcinoma
    Terashima, Takeshi
    HEPATOLOGY RESEARCH, 2020, 50 (07) : 773 - 774
12345